In routine clinical practice regarding breast cancer, the subtypes are commonly discerned through immunohistochemical markers, such as the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [31]. This evidence concerns the gene ERBB2 and breast cancer.